Revolution Medicines, Inc. (RVMD) Tops Q1 EPS by 10c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q1 EPS of ($0.72), $0.10 better than the analyst estimate of ($0.82). Revenue for the quarter came in at $7.01 million versus the consensus estimate of $2.5 million.

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
• Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08